English
Home > Products > 1029701-48-1

China 1029701-48-1 Factory

The client satisfaction is our primary concentrate on. We uphold a consistent level of professionalism, top quality, credibility and service for 1029701-48-1,CAS NO 1029701-48-1,Bortezomib intermediate,Bortezomib advance intermediate,2-Pyrazinecarboxamide, To significantly improve our assistance quality, our company imports a large number of international advanced devices. Welcome clients from your home and abroad to simply call and inquire!
1029701-48-1, We've got constantly insisted on the evolution of solutions, spent good funds and human resource in technological upgrading, and facilitate production improvement, meeting the wants of prospects from all countries and regions.

Related Products

Hot Products

  • alpha-Arbutin

    alpha-Arbutin

    Product Name:alpha-Arbutin
    Molecular Formula:C12H16O7
    Molecular Weight;272.25
    CAS Registry Number;84380-01-8
  • Triethylamine trihydrofluoride

    Triethylamine trihydrofluoride

    Product Name:Triethylamine trihydrofluoride
    Molecular Formula:C6H18F3N
    Molecular Weight:161.21
    CAS Registry Number:73602-61-6
  • 3-(2-chloropyriMidin-4-yl)-1-Methylindole

    3-(2-chloropyriMidin-4-yl)-1-Methylindole

    Product Name:3-(2-chloropyriMidin-4-yl)-1-Methylindole
    Molecular Formula:C13H10ClN3
    Molecular Weight:243.69
    CAS Registry Number:1032452-86-0
  • Paricalcitol

    Paricalcitol

    Product Name:Paricalcitol
    Molecular Formula:C27H44O3
    Molecular Weight;416.65
    CAS Registry Number;131918-61-1
  • N-Boc-3-Pyrrolidinone

    N-Boc-3-Pyrrolidinone

    Product Name:N-Boc-3-Pyrrolidinone
    Molecular Formula:C9H15NO3
    Molecular Weight:185.22
    CAS Registry Number:101385-93-7
  • Hydroxyprogesterone acetate

    Hydroxyprogesterone acetate

    Product Name:Hydroxyprogesterone acetate
    Molecular Formula:C23H32O4
    Molecular Weight:372.5
    CAS Registry Number:302-23-8
  • Related Blog
  • Reviews

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Related Search

CAS NO 1029701-48-1

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept